Newsroom :: CytoDyn Inc. (CYDY)

For the latest results and updates on our Phase 2 CRC trial and more, here’s a direct link to our recent presentations

Learn More

Guest Appearance on The Big Biz Show (Dr. Jacob Lalezari)

Jun 24, 2026

Video

CytoDyn Announces First Patient Dosed in Phase 2a Study in Collaboration with Weill Cornell Medicine Evaluating Leronlimab in Alzheimer’s Disease

Jun 11, 2026 8:30am EDT

Press Release

Natera and CytoDyn Announce Strategic Collaboration to Advance ctDNA-Guided Development and Molecular Response Analysis in Metastatic Colorectal Cancer

Jun 04, 2026 8:00am EDT

Press Release

LD Micro Conference Presentation (Robert Hoffman)

May 18, 2026

Video

CytoDyn to Present at the LD Micro Invitational XVI

May 15, 2026 8:30am EDT

Press Release

CytoDyn Announces First Patient Dosed in Expanded Access Program for Leronlimab in Triple-Negative Breast Cancer

Apr 27, 2026 8:30am EDT

Press Release

CytoDyn to Host Investor Webcast

Apr 23, 2026 8:30am EDT

Press Release

CytoDyn Presents New Leronlimab Data in Metastatic Colorectal Cancer at AACR Annual Meeting 2026

Apr 22, 2026 8:30am EDT

Press Release

CytoDyn Completes Enrollment in Phase 2 Metastatic Colorectal Cancer Study

Apr 21, 2026 4:10pm EDT

Press Release

CytoDyn Presents New Leronlimab Data in Metastatic Triple-Negative Breast Cancer at AACR Annual Meeting 2026

Apr 20, 2026 8:30am EDT

Press Release

1
2
3
4
5
6
7
8